ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited (ASLN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ASLN · as of Jun 9, 2026
Key Statistics
Explore ASLAN Pharmaceuticals Limited Data
asln stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
asln competitorsASLN
ALBO
CDMO
CMRX
EXAI
HARPStock Performance
Full HistoryAbout ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance pati…
what is aslan pharmaceuticals limited · asln stock overview · aslan pharmaceuticals limited company profile · who is aslan pharmaceuticals limited ceo · asln NASDAQ · aslan pharmaceuticals limited headquarters · aslan pharmaceuticals limited business segments
About Stock Overview & Key Data
ASLAN Pharmaceuticals Limited (ASLN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 4, 2018. As of the latest trading session, ASLN stock price is $0.60, with a market capitalization of $777.1M. The stock has returned -96.51% over the past 12 months and -86.36% year-to-date.
According to 4 Wall Street analysts, the consensus rating for ASLAN Pharmaceuticals Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, ASLAN Pharmaceuticals Limited reported revenue of $12.0M and net income of -$44.2M. For detailed data — including ASLAN Pharmaceuticals Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ASLAN Pharmaceuticals Limited (ASLN) stock price is $0.60. The stock is traded on NASDAQ under the ticker symbol ASLN. The 52-week range is $0.47 – $17.04.